COMMUNIQUÉS West-GlobeNewswire

Preclinical Data Showing Synergy of Biothera Pharmaceuticals’ Imprime PGG and a CD40 Agonist in a Pancreatic Cancer Model Presented at Keystone Symposia
26/03/2018
EAGAN, Minn., March 26, 2018 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. and the Abramson Cancer Center of the University of Pennsylvania announced today the presentation of new preclinical data demonstrating the [...]
Puerto Rican Alzheimer’s Patients to Be First in U.S. to Obtain Cannabis-Based Relief
26/03/2018
BETHESDA, Md. and SAN JUAN, Puerto Rico, March 26, 2018 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) – Alzheimer’s patients in Puerto Rico will be the first in the United States to obtain [...]
FDA approves inclusion of data on cardiovascular outcomes and severe hypoglycaemia in the Tresiba® label
26/03/2018
Bagsværd, Denmark, 26 March 2018 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an update to the US prescribing information for Tresiba ® (insulin degludec) to include data [...]
Millennium BlockChain Announces Major Investment in Online Broker Dealer ChoiceTrade
26/03/2018
Millennium BlockChain, first publicly traded company to conduct stock swaps for equity in blockchain companies, partners with ChoiceTrade to introduce the next generation of trading LAS VEGAS / SAN JUAN, PUERTO RICO, [...]
iKang Enters into Definitive Merger Agreement for Going Private Transaction
26/03/2018
BEIJING, March 26, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG ), a major provider in China’s fast growing private preventive healthcare services market, today [...]
TOMI Environmental Solutions, Inc. Secures EPA Registration in Taiwan
26/03/2018
BEVERLY HILLS, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ) a global company that specializes in plasma science based disinfection/decontamination technology using [...]
CohBar, Inc. Announces Financing of up to US$5,000,000 in Unsecured Promissory Notes
26/03/2018
MENLO PARK, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR ) and (TSXV:COB.U) (“CohBar” or the “Company”), a preclinical stage biotechnology company developing mitochondria based therapeutics to [...]
Bravo Becomes First National Wellness Vendor to Endorse Campaign for Universal Access to Health Promotion
26/03/2018
CLEVELAND, Ohio, March 26, 2018 (GLOBE NEWSWIRE) -- Today, Bravo, the leading national provider of employee well-being solutions known for success in measurable health risk reductions, announces its public support for [...]
Cesca Therapeutics Announces Registered Direct Offering
26/03/2018
RANCHO CORDOVA, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, announced that it has [...]
MyVii Foundation Releases new STD awareness campaign “Spread the AFFECTION not the INFECTION”
26/03/2018
TORONTO, March 26, 2018 (GLOBE NEWSWIRE) -- MyVii Foundation (Non-Profit) On February 13 th of this year, Maren Melnick discovered that several of her friends were recently diagnosed with an STD. That same day she [...]
Share buy-back week 12/2018
26/03/2018
Announcement 26 March 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]
Micron Solutions, Inc. Reports 2017 Fourth Quarter and Year End Results
26/03/2018
FITCHBURG, Mass., March 26, 2018 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American:MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]
Precision Therapeutics to Hold Business Update Conference Call on April 2, 2018
26/03/2018
MINNEAPOLIS, March 26, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical, a company focused on applying artificial intelligence to personalized [...]
Onconova Presents Promising Data from Phase 2 Expansion Study of Oral Rigosertib and Azacitidine Combination in Patients with Myelodysplastic Syndromes at 6th International Bone Marrow Failure Disease Symposium
26/03/2018
First presentation from dose exploration cohorts in an expanded trial addressing urinary safety of the novel combination therapy in higher risk patients with Myelodysplastic Syndromes (MDS) Study demonstrates [...]
Novo Nordisk A/S: Share repurchase programme
26/03/2018
Bagsværd, Denmark, 26 March 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Organovo Division Samsara Sciences Announces Multi-Year Supply Agreement With Lonza Bioscience Solutions
26/03/2018
SAN DIEGO, March 26, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today announced that its wholly-owned subsidiary, Samsara Sciences, Inc. (“Samsara”), a provider of highly specialized [...]
Physeon GmbH to Present at MedTech Strategist Innovation Summit - Dublin, Ireland April 17-19, 2018
26/03/2018
SCHAFFHAUSEN, Switzerland, March 26, 2018 (GLOBE NEWSWIRE) -- Physeon® GmbH, (“Physeon” or the “Company”), a leading developer of medical technology products for venous access, today announced that the Company will be a [...]
Drug Master File for Prostate Imaging Product Filed with the FDA
26/03/2018
MELBOURNE, Australia and INDIANAPOLIS, March 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix Group”, “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
Tauriga Sciences, Inc. Elects to Change the Name of its Recently Formed Delaware Subsidiary to: Tauriga Biz Dev Corp.
26/03/2018
NEW YORK, NY, March 26, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]

Pages